CAPONE, EMILY
 Distribuzione geografica
Continente #
NA - Nord America 1.881
AS - Asia 1.229
EU - Europa 1.128
SA - Sud America 166
AF - Africa 36
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 4.442
Nazione #
US - Stati Uniti d'America 1.829
SG - Singapore 600
IT - Italia 382
CN - Cina 245
IE - Irlanda 158
VN - Vietnam 158
BR - Brasile 136
RU - Federazione Russa 127
SE - Svezia 96
DE - Germania 83
IN - India 56
FR - Francia 47
FI - Finlandia 46
GB - Regno Unito 46
TR - Turchia 41
UA - Ucraina 37
BD - Bangladesh 32
CA - Canada 28
NL - Olanda 21
HK - Hong Kong 19
ZA - Sudafrica 17
AR - Argentina 15
PL - Polonia 14
AT - Austria 13
BE - Belgio 13
IQ - Iraq 10
ES - Italia 9
JP - Giappone 9
MX - Messico 9
AE - Emirati Arabi Uniti 8
KR - Corea 8
CH - Svizzera 7
EG - Egitto 7
LT - Lituania 6
UZ - Uzbekistan 6
GR - Grecia 5
PK - Pakistan 5
CZ - Repubblica Ceca 4
EC - Ecuador 4
JO - Giordania 4
HR - Croazia 3
JM - Giamaica 3
KE - Kenya 3
MA - Marocco 3
MY - Malesia 3
NI - Nicaragua 3
PE - Perù 3
TN - Tunisia 3
TW - Taiwan 3
VE - Venezuela 3
AZ - Azerbaigian 2
BB - Barbados 2
DK - Danimarca 2
DZ - Algeria 2
ID - Indonesia 2
IL - Israele 2
LB - Libano 2
PH - Filippine 2
PY - Paraguay 2
RO - Romania 2
RS - Serbia 2
UY - Uruguay 2
AO - Angola 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
CL - Cile 1
CR - Costa Rica 1
DM - Dominica 1
DO - Repubblica Dominicana 1
EU - Europa 1
GD - Grenada 1
GE - Georgia 1
HU - Ungheria 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LC - Santa Lucia 1
LU - Lussemburgo 1
MN - Mongolia 1
NP - Nepal 1
OM - Oman 1
PA - Panama 1
PS - Palestinian Territory 1
PT - Portogallo 1
QA - Qatar 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
Totale 4.442
Città #
Singapore 439
San Jose 235
Chandler 207
Dublin 156
Ashburn 146
The Dalles 82
Beijing 74
Dallas 72
Jacksonville 71
Santa Clara 63
Los Angeles 57
New York 57
Pescara 53
Princeton 53
Chieti 47
Council Bluffs 46
Ho Chi Minh City 44
Ann Arbor 43
Munich 35
Boardman 29
Altamura 27
Hanoi 27
Dong Ket 22
Buffalo 21
Dearborn 20
Izmir 18
Nanjing 18
Wilmington 18
Lappeenranta 17
Milan 17
Denver 16
Hong Kong 16
Montreal 16
Hefei 15
Tongling 15
Turku 14
Brussels 13
Rome 13
Atlanta 12
Frankfurt am Main 12
Johannesburg 12
Moscow 12
Stockholm 12
Warsaw 12
Brooklyn 11
Houston 11
L’Aquila 11
Nuremberg 11
Redondo Beach 11
São Paulo 11
Phoenix 10
Chennai 9
Da Nang 9
Helsinki 9
Pune 9
Orem 8
Southend 8
Tokyo 8
Cambridge 7
Falls Church 7
Haiphong 7
Hebei 7
London 7
Mumbai 7
Poplar 7
Seoul 7
Chicago 6
Dubai 6
Rio de Janeiro 6
Seattle 6
Tashkent 6
Vienna 6
Finale Ligure 5
Macerata 5
Nanchang 5
Ninh Bình 5
Norwalk 5
Perugia 5
Salvador 5
St Louis 5
Washington 5
Zurich 5
Amman 4
Baghdad 4
Belo Horizonte 4
Cairo 4
Castignano 4
Cleveland 4
Collecorvino 4
Putignano 4
Querétaro 4
Redwood City 4
San Francisco 4
Shanghai 4
Shijiazhuang 4
Woodbridge 4
Zhengzhou 4
Amsterdam 3
Biên Hòa 3
Boston 3
Totale 2.751
Nome #
miR-205-5p-mediated downregulation of ErbB/HER receptors in breast cancer stem cells results in targeted therapy resistance 218
EV20-mediated delivery of cytotoxic auristatin MMAF exhibits potent therapeutic efficacy in cutaneous melanoma 183
EV20-Sap, a novel anti-HER-3 antibody-drug conjugate, displays promising antitumor activity in melanoma 173
ABCC3 is a novel target for the treatment of pancreatic cancer 165
LGALS3BP antibody-drug-conjugate and its use for the treatment of cancer 162
Secreted Gal-3BP is a novel promising target for non-internalizing Antibody–Drug Conjugates 152
Pharmacological inhibition of ABCC3 slows tumour progression in animal models of pancreatic cancer 152
ErbB-3 activation by NRG-1β sustains growth and promotes vemurafenib resistance in BRAF-V600E colon cancer stem cells (CSCs) 151
Generation of a novel Antibody-Drug Conjugate targeting endosialin: potent and durable antitumor response in sarcoma 150
Repurposing a psychoactive drug for children with cancer: p27 Kip1-dependent inhibition of metastatic neuroblastomas by Prozac 147
Extracellular vesicles in glioblastoma: Biomarkers and therapeutic tools 140
Dual targeting of ErbB-2/ErbB-3 results in enhanced antitumor activity in preclinical models of pancreatic cancer. 135
BAG3 induces fibroblasts to release key cytokines involved in pancreatic cell migration 134
HPLC-DAD validated method for DM4 and its metabolite S-Me-DM4 quantification in biological matrix for clinical and pharmaceutical applications 132
Targeting vesicular lgals3bp by an antibody-drug conjugate as novel therapeutic strategy for neuroblastoma 126
A first-in-class non-cytotoxic nanocarrier based on a recombinant human ferritin boosts targeted therapy, chemotherapy and immunotherapy 124
HER-3 surface expression increases in advanced colorectal cancer representing a potential therapeutic target 123
Normal breathing releases SARS-CoV-2 into the air 123
EV20‑sss‑vc/MMAF, an HER‑3 targeting antibody‑drug conjugate displays antitumor activity in liver cancer 117
LGALS3BP antibody-drug conjugate enhances tumor-infiltrating lymphocytes and synergizes with immunotherapy to restrain neuroblastoma growth 114
Antibody-drug conjugates: The new frontier of chemotherapy 113
Anti-LGALS3BP antibody-drug conjugate treatment induces durable and potent antitumor response in a preclinical model of adenoid cystic carcinoma 111
HER3 targeting with an antibody-drug conjugate bypasses resistance to anti-HER2 therapies 111
Preclinical validation of 3-phosphoinositide-dependent protein kinase 1 inhibition in pancreatic cancer 111
EV20, a Novel Anti-ErbB-3 Humanized Antibody, Promotes ErbB-3 Down-Regulation and Inhibits Tumor Growth In Vivo. 109
Extracellular LGALS3BP: a potential disease marker and actionable target for antibody-drug conjugate therapy in glioblastoma 108
Dual PDK1/aurora kinase a inhibitors reduce pancreatic cancer cell proliferation and colony formation 104
HER-3: Hub for escape mechanisms 96
Endosialin-binding antibody 94
EV20/NMS-P945, a Novel Thienoindole Based Antibody-Drug Conjugate Targeting HER-3 for Solid Tumors 93
Evaluation of Antibody-Drug Conjugate Performances Using a Novel HPLC-DAD Method for Tumor-Specific Detection of DM4 and S-Methyl-DM4 84
MYC regulates metabolism through vesicular transfer of glycolytic kinases 84
EV20/Omomyc: A novel dual MYC/HER3 targeting immunoconjugate 82
LGALS3BP is a potential target of antibody-drug conjugates in oral squamous cell carcinoma 81
Visualizing Galectin-3 Binding Protein Expression with ImmunoPET 79
Role of galectin 3 binding protein in cancer progression: a potential novel therapeutic target 70
Osimertinib and anti-HER3 combination therapy engages immune dependent tumor toxicity via STING activation in trans 66
Therapeutic potential of antibody‐drug conjugate‐based therapy in head and neck cancer: A systematic review 63
Glycosylated LGALS3BP is highly secreted by bladder cancer cells and represents a novel urinary disease biomarker 45
Totale 4.625
Categoria #
all - tutte 19.324
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.324


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022175 6 3 4 25 16 11 11 12 17 8 14 48
2022/2023539 43 97 35 65 46 86 20 45 64 12 18 8
2023/2024343 18 10 41 17 18 111 49 12 0 14 11 42
2024/20251.022 34 180 162 53 21 39 42 48 128 69 152 94
2025/20261.964 154 70 138 218 228 131 382 97 180 206 107 53
2026/202715 15 0 0 0 0 0 0 0 0 0 0 0
Totale 4.625